GlassScriptPhysician profile
Scott Nguyen
NPI 1427721661
$4,374.69
in general payments reported to CMS, 2019-2025
16 companies · $1,824 in 2025
The $1,824 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $39.69 · 2023: $679 · 2024: $1,832 · 2025: $1,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,335.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $852.40 | 2023-2025 | Cequa |
| Bausch & Lomb Americas INC. | $627.21 | 2024-2025 | Miebo, Infuse, Xiidra |
| Alcon Vision LLC | $483.43 | 2023-2025 | Rocklatan, Tryptyr, Eysuvis |
| Dompe US, INC. | $444.21 | 2024-2025 | Oxervate |
| Abbvie INC. | $381.14 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $379.12 | 2024-2025 | Xdemvy |
| Amgen INC. | $321.15 | 2024-2025 | Tepezza |
| Oyster Point Pharma, INC. | $287.98 | 2023-2024 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $151.09 | 2024-2025 | |
| Horizon Therapeutics Plc | $126.65 | 2023 | Tepezza |
| Sight Sciences, INC. | $101.24 | 2025 | Tearcare System |
| Thea Pharma INC. | $92.27 | 2023-2025 | Iyuzeh |
| Johnson & Johnson Vision Care, INC. | $49.92 | 2024-2025 | |
| Rxsight INC | $48.78 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Apellis Pharmaceuticals, INC. | $14.42 | 2025 | Syfovre |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $13.68 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.